State Street’s SeaStar Medical ICU Stock Holding History

State Street’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-238	Closed	-$43.6K	–	4377
2024 Q1	$43.6K	Hold	238	–	–	﹤0.01%	4186
2023 Q4	$26.3K	Buy	238 +196	+467%	+$29K	﹤0.01%	4309
2023 Q3	$2.8K	Hold	42	–	–	﹤0.01%	4550
2023 Q2	$5.53K	Hold	42	–	–	﹤0.01%	4660
2023 Q1	$19.7K	Buy	+42	New	+$35.8K	﹤0.01%	4684

Other funds holding ICU

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

State Street's ICU Position: Q2 2024 in Review

State Street sold out of SeaStar Medical (ICU) in Q2 2024, closing a stake of 238 shares — an estimated $43.6K sold.

State Street first reported a position in ICU in Q1 2023 and held it in 5 quarters. The position peaked at $43.6K in Q1 2024. 16 funds tracked by Wall St. Rank hold ICU as of Q2 2024.

State Street reported no remaining SeaStar Medical position as of Q2 2024 after selling out during the quarter.
State Street sold 238 SeaStar Medical shares in Q2 2024, an estimated $43.6K.
State Street first reported a position in SeaStar Medical in Q1 2023 and held it in 5 quarters.
State Street's SeaStar Medical position peaked at $43.6K in Q1 2024.
16 funds tracked by Wall St. Rank held SeaStar Medical as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.